je.st
news
Tag: bet
Teva Pharmaceutical: An Ambitious Bet
2015-01-23 04:27:12| Biotech - Topix.net
Teva Pharmaceutical Industries Ltd has a strong competency in neurology and respiratory and is well-equipped to make generic acquisitions in key markets. Teva will bolster its market with complex generics, deals in new technologies and investments in emerging economies.
Tags: bet
pharmaceutical
ambitious
teva
Don't Bet On A Yelp Buyout
2015-01-19 17:33:40| Grocery - Topix.net
The rumors were absurd because we think at its current valuation, a buyout offer would be in the $60 region. We've kept an eye on Yelp over the last couple of months.
Soros bought into Santander share sale, raising bet on Spain
2015-01-12 20:46:50| IT Services - Topix.net
Soros Fund Management took part in Santander's 7.5-billion-euro share sale, completed over several hours last Thursday, with a 500-million-euro investment, the source said, speaking anonymously because the matter isn't public. An investment of that size would give Soros' fund a roughly 0.66 percent stake in the euro zone's biggest bank, according to calculations using Thomson Reuters data, although these do not take into account the new shares to be issued.
Merck Acquires OncoEthix, a Privately Held Oncology Company Developing Novel BET Inhibitors for Hematological and Solid Cancers
2014-12-18 13:30:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. Acquisition Expands Mercks Oncology Portfolio with Novel Oral BET Inhibitor, OTX015 KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that it has acquired, through a subsidiary, OncoEthix, a Swiss-based privately held biotechnology company specializing in oncology drug development. Through the acquisition, Merck has gained an investigational, novel oral BET (bromodomain) inhibitor, OTX015, which is currently in Phase 1b studies for the treatment of hematological malignancies and advanced solid tumors. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Claire Mulhearn, 908-236-1118orInvestors:Joseph Romanelli, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: company
held
solid
developing
Pete Najarian's Bullish Bet On Cypress Semiconductor Corporation
2014-12-14 03:13:03| Electronics - Topix.net
Cypress Semiconductor Corporation has recently announced it merger with another semiconductor company, Spansion Inc. . This merger announcement has pushed the Cypress Semiconductor Corporation 's stock price up by around 20% and post this announcement on Dec 1, this stock grew consistently and has achieved a growth of more than 30% in the last couple of weeks.
Tags: corporation
bet
pete
semiconductor
Sites : [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] next »